Literature DB >> 32459545

Effect of In Vivo Expansion of Regulatory T Cells with IL-2/anti-IL-2 Antibody Complex Plus Rapamycin on Experimental Autoimmune Uveoretinitis.

Yasuhiko Sato1,2, Hiroshi Keino1, Makiko Nakayama1, Mirai Kano1, Annabelle A Okada1.   

Abstract

Purpose: To determine the effect of injection of IL-2/anti-IL-2 antibody (IL-2 complex) together with rapamycin on the development of experimental autoimmune uveoretinitis (EAU).
Methods: C57BL/6J mice were immunized with human interphotoreceptor retinoid-binding protein peptide. The immunized mice were injected intraperitoneally with PBS, IL-2 complex, rapamycin, or IL-2 complex/rapamycin on days 1, 2, 3, and 4 (induction phase) or days 10, 11, 12, and 13 (effector phase) after immunization.
Results: Expansion of CD4+Foxp3+ regulatory T cells in draining lymph nodes was observed in IL-2 complex and IL-2 complex/rapamycin-treated mice. Although injection of IL-2 complex alone was not capable of decreasing the clinical score of EAU, injection of IL-2 complex/rapamycin significantly delayed the onset of EAU. In contrast, the treatment with IL-2 complex alone or IL-2 complex/rapamycin during effector phase failed to suppress EAU.Conclusions: These findings suggest the potential limitations of IL-2 complex or IL-2 complex/rapamycin during EAU.

Entities:  

Keywords:  Experimental autoimmune uveoretinitis; Foxp3; IL-2; rapamycin; regulatory T cells

Mesh:

Substances:

Year:  2020        PMID: 32459545     DOI: 10.1080/09273948.2020.1757119

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  1 in total

1.  Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19.

Authors:  Meng-En Zhu; Qian Wang; Shaoqiong Zhou; Bin Wang; Li Ke; Ping He
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.